Skip to search formSkip to main contentSkip to account menu

velafermin

Known as: Recombinant FGF-20, Recombinant Human Fibroblast Growth Factor-20, rhFGF-20 
A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity. Velafermin stimulates DNA synthesis and cell… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Purpose: Velafermin (recombinant human fibroblast growth factor-20, rhFGF-20) has been shown to reduce the severity and duration… 
2008
2008
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept… 
2007
2007
Mucositis is a common, costly and unpleasant side effect of cancer chemotherapy and radiotherapy. Velafermin (FGF-20) has shown… 
2007
2007
Goals of workThe objective of this study was to evaluate the safety and tolerability of velafermin in patients at risk of… 
Review
2007
Review
2007
Oral mucositis (OM) is a commonly occurring side effect in patients (pts) undergoing AHSCT. Velafermin, recombinant human… 
2007
2007
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA 3758 Oral mucositis is a debilitating side effect of chemotherapy and… 
2006
2006
6537 Background: Oral mucositis (OM) is a commonly occurring side effect of high-dose chemotherapy (HDCT) in patients (pts… 
2006
2006
Objective:To express and purify bioactive recombinant human fibroblast growth factor-20(rhFGF-20)protein and to prepare its… 
2005
2005
  • Rajesh V Lalla
  • Current opinion in investigational drugs
  • 2005
  • Corpus ID: 21524627
CuraGen is developing velafermin (CG-53135), human fibroblast growth factor-20 administered intravenously, for the potential… 
2005
2005
Oral mucositis (OM) is a treatment-limiting condition associated with myelosupressive chemotherapy and radiation therapy. The…